Rigetti Computing, Inc. (RGTI)

Executive Summary

Rigetti Computing rebounded 5.25% to $21.77 following Bernstein's bullish quantum computing sector analysis, which identified RGTI as having 60% upside potential to a $33 price target. This recovery partially offsets the previous session's 9.97% decline, though the stock remains in a volatile consolidation phase 22.98% below its six-month high. The investment thesis remains intact with $590 million in cash providing substantial runway, though competitive pressure from Quantinuum's successful $15.6 billion IPO and sector-wide valuation concerns warrant continued caution.

Key Updates

Rigetti Computing gained 5.25% to $21.77 since the June 6th report, recovering from the prior session's sharp decline. The rally was catalyzed by Bernstein's sector analysis positioning RGTI alongside Infleqtion as the quantum stocks with "most upside," citing Mizuho's $33 price target (60% upside from $20.68 reference price). Bernstein's framework positions quantum computing as a specialized accelerator within a tri-processor architecture alongside CPUs and GPUs, validating the long-term thesis while acknowledging modality-specific use cases. The analysis highlighted RGTI's $590 million cash position as a competitive strength, providing financial stability during the commercialization phase.

Current Trend

RGTI remains down 1.74% year-to-date at $21.77, underperforming broader tech indices despite government funding catalysts. The stock has experienced extreme volatility: up 14.92% over one month following the May 21st $100 million government funding announcement, but down 22.98% from six-month highs and down 15.08% over five days. The recent price action shows a pattern of sharp rallies followed by aggressive profit-taking, with the stock establishing support around $20.68 (June 6th low) and facing resistance near $24-25 levels. Trading volume remains elevated relative to pre-funding announcement levels, indicating continued active positioning by both institutional and retail participants.

Investment Thesis

The investment thesis centers on RGTI's positioning as a pure-play superconducting quantum computing company with substantial government backing and adequate capitalization for technology development. The $100 million government grant from the Trump administration's $2 billion quantum initiative validates RGTI's technology approach and provides non-dilutive funding. With $590 million in cash, the company maintains a stronger balance sheet than most quantum computing peers, enabling sustained R&D investment without immediate capital market dependency. The superconducting modality represents one of several competing quantum approaches, with different technologies suited to specific use cases and time horizons according to Bernstein's analysis. RGTI's market capitalization implies only 4% long-term market share in quantum computing according to Bernstein, suggesting significant upside if execution improves or market share assumptions prove conservative.

Thesis Status

The investment thesis remains fundamentally intact but faces increased near-term headwinds from competitive dynamics. Quantinuum's successful $15.6 billion IPO establishes a formidable competitor with superior scale, deeper partnerships (Honeywell maintaining 49% voting control), and a full-stack hardware/software approach. While Quantinuum's flat post-IPO trading performance (closing essentially flat despite opening 13% higher) suggests investor caution toward quantum valuations, the company's ability to raise $1.68 billion at a $15.6 billion valuation demonstrates institutional appetite for market leaders. RGTI's significantly smaller scale ($590 million cash vs. Quantinuum's $1.68 billion fresh capital) positions it as a higher-risk, higher-reward play dependent on technology differentiation and niche market capture. The Bernstein endorsement and Mizuho $33 price target provide analytical support, but execution risk remains elevated given the company's earlier-stage commercialization status relative to better-capitalized competitors.

Key Drivers

Positive Catalysts: Bernstein's bullish sector analysis identifying RGTI as having 60% upside to Mizuho's $33 target provides near-term momentum and validates the investment case. The $100 million government funding from the Trump administration's $2 billion quantum initiative delivers non-dilutive capital and strategic validation. RGTI's $590 million cash position provides multi-year runway for technology development without dilution pressure. The tri-processor architecture framework articulated by Bernstein positions quantum as complementary to existing computing infrastructure rather than replacement technology, expanding total addressable market assumptions.

Risk Factors: Quantinuum's $15.6 billion valuation and $1.68 billion capital raise establishes a significantly better-capitalized competitor with full-stack capabilities and Honeywell backing. The muted post-IPO performance (flat close despite 13% opening gain) signals investor caution toward quantum valuations broadly. RGTI's 22.98% decline from six-month highs and persistent volatility (15.08% five-day decline preceding current rally) reflects ongoing uncertainty about commercialization timelines and competitive positioning. The company's implied 4% long-term market share according to Bernstein analysis highlights the binary risk profile—substantial upside if execution improves, but meaningful downside if competitive differentiation fails to materialize.

Technical Analysis

RGTI is trading at $21.77 following a 5.25% single-day recovery from the $20.68 support level established on June 6th. The stock has formed a volatile consolidation pattern between $20.68 support and $24-25 resistance over the past week, with the current price positioned in the lower-middle portion of this range. The one-month chart shows a clear pattern: sharp rally to post-funding highs, followed by 22.98% correction from six-month peaks, and now attempting to establish a base. Volume remains elevated compared to pre-May 21st levels, indicating active institutional repositioning. The 14.92% one-month gain contrasts sharply with the 1.74% YTD decline, illustrating the stock's binary response to catalysts. Key technical levels: immediate support at $20.68 (recent low), secondary support at $18-19 (pre-funding announcement levels), resistance at $24-25 (recent consolidation highs), and major resistance at $28+ (six-month highs). The stock needs to reclaim and hold above $24 to confirm bullish continuation; failure to hold $20.68 support would likely trigger another leg down toward $18.

Bull Case

• Bernstein Endorsement with 60% Upside Target: Bernstein analysts identified RGTI as one of two quantum stocks with "most upside," citing Mizuho's $33 price target representing 60% appreciation from $20.68 reference price, providing strong analytical support for current valuation levels.
• Substantial Cash Position: RGTI maintains approximately $590 million in cash, providing multi-year runway for technology development without near-term dilution risk and positioning the company as better-capitalized than most quantum computing peers outside of Quantinuum.
• Government Validation and Funding: The $100 million government grant from the Trump administration's $2 billion quantum initiative provides non-dilutive capital and strategic validation of RGTI's superconducting technology approach alongside larger competitors like IBM.
• Undervalued Market Share Assumptions: Current valuation implies only 4% long-term market share in quantum computing according to Bernstein analysis, suggesting significant upside if the company captures even modest additional share in the emerging $850 billion market projected by 2040.
• Tri-Processor Architecture Thesis: Bernstein's framework positioning quantum as a specialized accelerator alongside CPUs and GPUs expands the total addressable market by framing quantum as complementary rather than replacement technology, reducing adoption friction and broadening use cases.

Bear Case

• Quantinuum Competition at Massive Scale: Quantinuum's $15.6 billion valuation and $1.68 billion capital raise establishes a competitor with 3x more fresh capital than RGTI's total cash position, full-stack hardware/software capabilities, and Honeywell's 49% backing, creating significant competitive disadvantage in resources and partnerships.
• Sector Valuation Concerns: Quantinuum's flat post-IPO performance despite opening 13% higher signals growing investor caution toward quantum computing valuations broadly, contrasting with AI chipmaker Cerebras's 70% opening-day gain and suggesting quantum sector may face valuation compression.
• Persistent Volatility and Downtrend: The stock remains down 22.98% from six-month highs and declined 15.08% over five days preceding the current rally, demonstrating inability to sustain gains and suggesting weak investor conviction despite positive catalysts.
• Technology Modality Risk: Bernstein's analysis notes different quantum modalities are suited to specific use cases and time horizons, creating risk that RGTI's superconducting approach may prove less commercially viable than competing technologies like neutral-atom (Infleqtion) or trapped-ion (Quantinuum) approaches.
• Commercialization Uncertainty: Quantinuum's $192.6 million net loss on $30.9 million revenue in 2025 demonstrates even the sector leader operates at massive losses, highlighting extended commercialization timelines that disproportionately impact smaller players like RGTI with limited revenue visibility and higher cash burn risk relative to capital base.